Clinical trials
Terminated Immunoglobulin Light-chain Amyloidosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boston Medical Center | 4 |
| Prothena Biosciences Ltd. | 3 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| City of Hope Medical Center | 1 |
| Eastern Cooperative Oncology Group | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| GlaxoSmithKline | 1 |
| M.D. Anderson Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunoglobulin Light-chain Amyloidosis | 22 |
| Multiple Myeloma | 10 |
| Neoplasms, Plasma Cell | 8 |
| Burkitt Lymphoma | 6 |
| Hodgkin Disease | 6 |
| Leukemia | 6 |
| Leukemia, Hairy Cell | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 |
| Leukemia, Myeloid, Acute | 6 |
| Leukemia, Myelomonocytic, Chronic | 6 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.